ABSTRACT OBJECTIVE: Our study aimed to investigate the possible modifying effects of leptin and combined use of resveratrol on rat renal I/R injury and their relationship on signal pathways and apoptosis-related mechanisms. BACKGROUND: Renal ischemia-reperfusion (I/R) injury is an important cause of acute renal failure. METHODS: Male Sprague Dawley rats were divided into 5 groups: Control, I/R, I/R+leptin, I/R+resveratrol and I/R+leptin+resveratrol. Leptin (10 μg/kg BW) was administered (i.p.) 30 min prior to I/R. Resveratrol was administered by gavage at 20 mg/kg BW per d for 12 d prior to I/R. The left renal artery was exposed to 1 h of ischemia and 1 h of reperfusion. RESULTS: Resveratrol treatment alone increased TNF-α, TNF-α R1, NF-κB, SIRT-1, STAT1 and STAT3 mRNA levels and decreased caspase 3 protein levels. Leptin treatment alone signifi cantly decreased the caspase 3 protein levels. The combined use of resveratrol and leptin signifi cantly increased STAT3, and caspase 3 mRNA levels, and decreased the caspase 3 protein levels. Apoptosis was signifi cantly decreased especially in the leptin and leptin+resveratrol groups. CONCLUSION: The present study suggest that a combined use of resveratrol and leptin has preventive and regulatory effects on renal I/R injury; the mechanism involves decreasing apoptosis, likely by altering the JAK/ STAT pathway and SIRT1 expression (Fig. 8, Ref. 24) . Text in PDF www.elis.sk.
Introduction
Leptin, a protein hormone that contains 167 amino acids, is known to induce many metabolic effects via the JAK/STAT signaling pathway. Our previous studies reported that leptin has a protective effect on renal I/R model induced by 1 hour of ischemia following 1 hour of reperfusion (1) . Another study showed the protective effects of resveratrol against oxidative stress on cardiac I/R model in the same time periods (2) . Smith et al investigated the role of the JAK/STAT pathway in the cardioprotective effects of resveratrol and suggested that the effects may involve leptin-induced STAT3 phosphorylation (3) . Resveratrol, a natural polyphenol compound, has many biochemical and physiological effects, including anti-infl ammatory, antioxidant, antiapoptotic and antiproliferative effects (2) . Recent studies have suggested that resveratrol may protect against ischemic damage in skeletal muscle, heart and brain (2, 4) . Nevertheless, the molecular mechanisms of resveratrol action are not yet clarifi ed. The in vivo antioxidant and anti-infl ammatory effects of resveratrol may be mediated by Sirtuin-1 (SIRT-1) (5). Similar to resveratrol, leptin has antioxidant, antiapoptotic and anti-infl ammatory effects and causes an increase in SIRT1 gene expression (6) . Although in vitro studies have reported that resveratrol may abrogate acute stress by increasing SIRT1 gene expression (5, 7) , there are no in vivo studies, to our knowledge, on SIRT1 gene expression in renal I/R injury.
TNF-α, a proinfl amatory cytokine released by many cell types, plays a central role in ischemia-reperfusion (I/R) injury. These roles are well presented in liver and myocardiac tissues (8, 9) . It is also well known that TNF-α plays a critical role in many types of kidney damage and TNF-α Receptor 1 (TNF-α R1) is the key mediator of this role by causing apoptosis (10) . TNF-α is induced both directly and indirectly by Nuclear factor-κB (NF-κB) in infl amation occured in I/R degeneration (11). Spandou et al (12) suggested that NF-κB activation may have a crucial role in the pathogenesis of several renal diseases. Our previous studies reported leptin treatment of the I/R group caused a marked decrease in the TNF-α values compared to I/R alone in rat bladder tissues (13). Gualdoni et al showed that the use of resveratrol increased the level of TNF-α soon after application (14) . However, the molecular mechanisms and interaction between TNF-α and these two agents at the level of cellular pathways have not been clarifi ed.
The aim of this study is to investigate the possible modifying effects of acute leptin, chronic resveratrol and combined treatment on renal I/R injury-related molecular mechanisms such as TNF-α, JAK/STAT SIRT1 pathways and their relation with apoptosis in rats.
Method
The Eskisehir Osmangazi University Institutional Local Animal Care and Use Committee (314/2012) approved all experimental procedures.
Design and treatments
A total of 40 male Sprague-Dawley rats weighing 200-250 g and aged 3-4 months were randomly assigned to experimental group. All rats were anesthetized by an intraperitoneal (i.p.) injection of ketamine and xylazine. The study groups (n = 8) were as follows: Group A: Control animals, group B: I/R, group C: I/R+leptin, group D: I/R+resveratrol, group E: I/ R+leptin+resveratrol. No surgical procedure was performed in control animals, saline was injected 60 min before anesthesia. Intraperitoneal saline was injected 60 min before the I/R procedures. For rats in the I/R+leptin group, 10 μg/kg of leptin was given intraperitoneally to the animals 60 min before the I/R procedure. For rats in the I/R+resveratrol group, 20 mg/kg of resveratrol was given by oral gavage for 14 days before the I/R procedure. For rats in I/R+leptin+resveratrol group, animals were treated with 20 mg/kg of resveratrol given by oral route for 14 days, followed by an intraperitoneal injection of 10 μg/kg of leptin 60 min before the I/R procedure.
Surgical operation and sample collection
Under aseptic conditions, a midline incision was performed in the ventral part of the body. In control group after 2 hours of anesthesia, kidneys and blood samples were withdrawn. In I/R groups, a non-traumatic vascular clamp was applied to the left renal artery to interrupt the blood fl ow for 60 min (ischemia), followed by removal of the clamp for 60 min (reperfusion). At the end of the reperfusion period, the animals were euthanized, blood samples and left kidney were collected. The I/R procedure and the post-I/R procedures were performed in B, C, D, E groups.
RNA Extraction and Real-Time PCR
Total RNA was extracted from approximately 100 mg of tissue using tripure solution according to the manufacturer's instructions (Roche, Mannheim, Germany). RNA concentration and purity were analyzed by measuring the optical density at 260 nm (NanoDrop 1000, Thermo Scientifi c, USA). One microgram of RNA was converted to cDNA using cDNA Synthesis Kit (Roche Nano Lightcycler Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. The abundance of TNF-α, TNF-α R1, NF-κB, SIRT-1, STAT1, STAT3 and caspase 3 mRNA were analyzed according to the manufacturer's instructions, using the beta-actin as a reference gene and Roche Nano Lightcycler (Roche Diagnostics, Mannheim, Germany).
Protein isolation and western blotting
Total protein was extracted from approximately 100 mg of tissue using tripure solution according to the manufacturer's instructions (Roche). The protein concentration was measured using spectroscopy (NanoDrop). Then, 80-μgr samples were placed into the wells of 10 % SDS-Polyacrylamide gels to separate the samples into bands by their molecular weight by using electrophoresis. After completing the electrophoresis, the gels were transferred to nitrocellulose membranes (Bio-Rad CA, USA) and incubated with rabbit anti-caspase 3 antibodies (1:1,000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). The secondary antibody (antirabbit IgG, Santa Cruz Biotechnology) was diluted 10,000-fold. All incubations were performed in Tris-HCl buffer, pH 7.5, with 0.1 % Tween 20 and 5 % dry milk. Dry milk was not added for the fi nal washing. Immunodetection was performed using chemiluminescence (West-Dura, Thermo Scientifi c, Waltham, MA). The signal intensity was determined by densitometry (ChemiDoc-It Imaging System, UVP Inc., Upland, CA), and the means and SDs were calculated for each tissue type.
DNA nick end-labeling of tissue sections
For the detection of apoptosis in tissues, a TUNEL-based apoptosis kit (Cat. no. S7101; ApopTag Plus Peroxidase Kits, Chemicon International, USA) was used. In this method, the sections were fi rst deparaffi nized and rehydrated. They were then permeabilized with proteinase K and endogen peroxidase, inactivated by 10 % H 2 O 2 . For DNA labeling, Tdt Labeling reaction mix and Tdt Enzyme mixture were used. Following incubation, the reaction was detected with conjugate and diaminobenzidine (DAB) solution in H 2 O 2 /urea mixture. Methyl green (3%) was used for counterstaining. The slides were then dehydrated and mounted. The TUNEL-positive brown-colored cells were considered to be apoptotic cells, in agreement with the positive control supplied by the manufacturer.
Statistical analysis
Transcript data were expressed relative to the control (set to 1) ± standard. Statistical analysis was performed by using the GraphPad software program. Following the determination of TNF-α, TNF-α R1, NF-κB, SIRT-1, STAT1, STAT3 and Caspase3 mRNA gene expression using beta-actin as a reference gene, the data obtained from RT PCR were calculated using the formula 2 −ΔΔCt . The WB results were analyzed by using one-way ANOVA (Tukey's test). Histological results were analyzed using the non-parametric Krusskal Wallis test and the intergroup differences were analyzed by Dunn's test. 
Results

Real-time PCR
TNF-α mRNA abundance was not signifi cantly different in the leptin group but was signifi cantly higher in the resveratrol group compared with the control group (p < 0.01, A vs D) (Fig.  1A) . TNF-α R1 mRNA abundance was signifi cantly increased in all groups compared with the control group (p < 0.05 A vs B, C, p < 0.001 A vs D, E) (Fig. 1B) . Similar to TNF-α, the NF-κB mRNA abundance was signifi cantly higher in the resveratrol group than in the control group (p < 0.001 A vs D) (Fig. 2) . SIRT1 mRNA abundance was signifi cantly higher in the resveratrol group than in the control group (p < 0.05 A vs D) (Fig. 3) . The STAT1 mRNA abundance measured by RT-PCR was signifi cantly higher in the resveratrol group compared with the control group (p < 0.05, A vs D) (Fig. 4) . STAT3 mRNA abundance increased signifi cantly in the resveratrol and leptin+resveratrol groups compared with the control group (p < 0.05 A vs D, p < 0.01 A vs E) (Fig. 5) . Caspase3 mRNA abundance was signifi cantly higher in the leptin+resveratrol than in the control group (p < 0.01 A vs E) (Fig. 6A) .
Western Blot
The caspase 3 protein level signifi cantly decreased in the leptin, resveratrol and leptin+resveratrol groups compared with the control group (p < 0.05 A vs C, p < 0.001 A vs D, E and B vs C, D, E) (Fig. 6B) .
Histological analysis results
For the calculation of apoptotic index, TUNEL (+) tubular epithelial cells were counted in 10 randomly selected fi elds under 20X magnifi cation. Histological evaluation of apoptosis detected by TUNEL staining revealed a marked apoptosis in the I/R group, which was decreased signifi cantly in all of the treatment groups but had a more pronounced effect in the leptin and leptin+resveratrol groups (p < 0.001, B vs C, D, E) (Figs 7 and 8A-E).
Discussion
The results of the present study showed that renal tissue injury was modifi ed in the leptin and leptin+resveratrol groups by keeping the TNF-α mRNA expression similar to that of the control group. Ghanim has reported that TNF-α levels were increased shortly after resveratrol administration (15) . It is parallel in our study; we also measured increased TNF-alpha levels just after resveratrol treatment. TNF-α R1 mRNA level signifi cantly increased in all groups compared to control group. However, this increase was impressive in resveratrol and leptin+resveratrol groups. These all results suggest that the use of resveratrol alone increases the levels of TNF-α soon after application, however the combined use of resveratrol with leptin modifi es the tissue injury by decreasing the TNF-α level to the control levels. NF-κB, signaling is described as one of the major transcriptional regulators of TNF-α expression (16). Gualdoni et al have also reported that treatment with resveratrol increases NF-κB expression in human monocytes in a dose-dependent manner (14) . In our study, parallel to TNF-α mRNA level, NF-κB mRNA level also increased in resveratrol treated groups, indicating that enhanced TNF-α production in the groups was caused by triggering NF-κB, signaling. Resveratrol has antiapoptotic effects by increasing the expression of SIRT1 gene, a member of sirtuins (6) . SIRT1 plays a pivotal role in regulation of NF-κB-dependent proinfl ammatory mediator expression. Many studies in different tissues have shown that effects of resveratrol are via modulation of NF-κB (17) . Although these effects have been confi rmed in in vitro studies (5, 7) , there are no in vivo studies investigating the role of SIRT1 gene expression in renal I/R injury. According to our study, we showed that SIRT1 mRNA expression was found to be increased in the resveratrol-treated group compared with the control and I/R groups in rats. Several I/R studies demonstrated the contribution of the JAK/STAT pathway to injury in various tissues (18) (19) (20) . In an in vitro study performed by Cao et al, a knockdown of STAT-1 gene expression decreased apoptosis induced by TNF-α and TNF-α also increased STAT-1 phosphorylation (21). Luna-Ortiz et al reported that TNF-α interact with JAK/STAT pathway and phosphorylates STAT-3 (22) . Similar to those studies, our results suggest that the increase in TNF-α in resveratrol-treated group results in an increased JAK/STAT pathway activity via increasing STAT-1 and STAT-3 mRNA expression. Smith et al reported the role of the JAK/STAT pathway in the cardioprotective effects of resveratrol and suggested that the effects may involve leptin-induced STAT3 phosphorylation (3). In our study also, the combined use of resveratrol with leptin modifi es the tissue injury by leptin-induced STAT3 phosphorylation. Caspase 3 is a key enzyme that leads to apoptosis in various cell types (23) . According to control group, although there was a small increase in caspase 3 protein expression in sham group, but this elevation was not signifi cant. Compared to similar studies we surmise that this nonsignifi cant result was due to a shorter reperfusion period (24). As consistent with apoptotic evaluation, renal caspase 3 protein expression was found to be decreased signifi cantly in the leptin-treated group. Conversely, caspase 3 mRNA expression was found to be increased in the leptin+resveratrol group compared with the control group. It may suggest that although there is suffi cient caspase 3 mRNA expression, the translation is defective, i.e., caspase 3 is inhibited at the protein synthesis level. However, according to TUNEL staining, apoptosis was signifi cantly more inhibited by leptin than in resveratrol and resveratrol + leptin treatment compared with the I/R group. Leptin showed modulatory effect on renal I/R injury by decreasing apoptosis, possibly through regulatory effects of the JAK/STAT signaling pathway and SIRT1 gene expression. On base of our experimental data, we suggest that the future clinical use of leptin-based therapies may exert protective effects on renal ischemia reperfusion injury.
